Qiming U.S. Ventures Management as of June 30, 2023
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 7 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Icosavax | 36.6 | $35M | 3.5M | 9.93 | |
| Ventyx Biosciences (VTYX) | 25.7 | $25M | 746k | 32.80 | |
| Jasper Therapeutics | 12.3 | $12M | 8.5M | 1.37 | |
| Hillevax (HLVX) | 10.1 | $9.6M | 559k | 17.19 | |
| Talaris Therapeutics | 9.4 | $8.9M | 2.9M | 3.04 | |
| Elevation Oncology (ELEV) | 3.8 | $3.6M | 2.4M | 1.52 | |
| Kezar Life Sciences (KZR) | 2.1 | $2.0M | 829k | 2.45 |
